Our reviews
Find a list of the topics that our reviews fall under below and navigate these to link to our reviews in the Cochrane Library:
Our reviews
| Status | Stage |
|---|---|
- Acupuncture and related interventions for smoking cessation
- Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
- Allergen-specific oral immunotherapy for peanut allergy
- Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women
- Antidepressants for smoking cessation
- Antifibrinolytic therapy to reduce haemoptysis from any cause
- Anxiolytics for smoking cessation
- Aversive smoking for smoking cessation
- Behavioural interventions for smoking cessation: an overview and network meta-analysis
- Biomedical risk assessment as an aid for smoking cessation
- Cannabinoid type 1 receptor antagonists for smoking cessation
- Clonidine for smoking cessation
- Combined pharmacotherapy and behavioural interventions for smoking cessation
- Community interventions for preventing smoking in young people
- Community interventions for reducing smoking among adults
- Community pharmacy personnel interventions for smoking cessation
- Competitions for smoking cessation
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
- Electronic cigarettes and subsequent cigarette smoking in young people
- Electronic cigarettes for smoking cessation
- Enhancing partner support to improve smoking cessation
- Exercise interventions for smoking cessation
- Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis
- Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke
- Family-based programmes for preventing smoking by children and adolescents
- Group behaviour therapy programmes for smoking cessation
- Healthcare financing systems for increasing the use of tobacco dependence treatment
- Heated tobacco products for smoking cessation and reducing smoking prevalence
- Hypnotherapy for smoking cessation
- Immunotherapy (oral and sublingual) for food allergy to fruits
- Impact of entertainment media smoking on adolescent smoking behaviours
- Impact of institutional smoking bans on reducing harms and secondhand smoke exposure
- Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours
- Incentives for preventing smoking in children and adolescents
- Incentives for smoking cessation
- Individual behavioural counselling for smoking cessation
- Internet-based interventions for smoking cessation
- Interventions for preoperative smoking cessation
- Interventions for preventing tobacco sales to minors
- Interventions for preventing weight gain after smoking cessation
- Interventions for recruiting smokers into cessation programmes
- Interventions for smokeless tobacco use cessation
- Interventions for smokeless tobacco use cessation
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Interventions for smoking cessation in hospitalised patients
- Interventions for tobacco cessation delivered by dental professionals
- Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders
- Interventions for tobacco use cessation in people living with HIV
- Interventions for waterpipe smoking cessation
- Interventions to increase adherence to medications for tobacco dependence
- Interventions to reduce harm from continued tobacco use
- Interventions to reduce tobacco use in people experiencing homelessness
- Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption
- Lobeline for smoking cessation
- Mass media interventions for preventing smoking in young people
- Mass media interventions for smoking cessation in adults
- Mecamylamine (a nicotine antagonist) for smoking cessation
- Mindfulness for smoking cessation
- Mobile phone text messaging and app-based interventions for smoking cessation
- Motivational interviewing for smoking cessation
- Nicobrevin for smoking cessation
- Nicotine receptor partial agonists for smoking cessation
- Nicotine replacement therapy versus control for smoking cessation
- Nicotine vaccines for smoking cessation
- Nursing interventions for smoking cessation
- Opioid antagonists for smoking cessation
- Oral and sublingual immunotherapy for egg allergy
- Oral immunotherapy for milk allergy
- Outpatient interventions for smoking cessation and reduction for adults with a mental disorder
- Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Pharmacological interventions for smoking cessation: an overview and network meta-analysis
- Physician advice for smoking cessation
- Print-based self-help interventions for smoking cessation
- Real-time video counselling for smoking cessation
- Relapse prevention interventions for smoking cessation
- School policies for preventing smoking among young people
- School-based programmes for preventing smoking
- Serum or plasma ferritin concentration as an index of iron deficiency and overload
- Silver acetate for smoking cessation
- Smoking cessation for improving mental health
- Smoking cessation for secondary prevention of cardiovascular disease
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Smoking cessation interventions for pulmonary tuberculosis treatment outcomes
- Smoking cessation interventions for smokers with current or past depression
- Smoking reduction interventions for smoking cessation
- Stage-based interventions for smoking cessation
- Strategies to improve smoking cessation rates in primary care
- System change interventions for smoking cessation
- Telephone counselling for smoking cessation
- The effect of individual-level smoking cessation interventions on socioeconomic inequalities in tobacco smoking
- Tobacco cessation interventions for young people
- Tobacco packaging design for reducing tobacco use
- Training health professionals in smoking cessation
- Use of electronic health records to support smoking cessation
- Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children
- Workplace interventions for smoking cessation
- Interventions at the population level (17)
- Community settings (2)
- Family settings (2)
- Governmental (4)
- Interventions for preventing tobacco sales to minors
- Healthcare financing systems for increasing the use of tobacco dependence treatment
- Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption
- Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours
- Institutional settings (2)
- Media and advertising (5)
- Mass media interventions for preventing smoking in young people
- Tobacco packaging design for reducing tobacco use
- Mass media interventions for smoking cessation in adults
- Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours
- Impact of entertainment media smoking on adolescent smoking behaviours
- School settings (2)
- Interventions to help smokers and other tobacco users to quit (66)
- For specific groups of smokers (13)
- Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
- Smoking cessation interventions for smokers with current or past depression
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Tobacco cessation interventions for young people
- Interventions for preoperative smoking cessation
- Smoking cessation interventions for pulmonary tuberculosis treatment outcomes
- Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders
- Pharmacological interventions for promoting smoking cessation during pregnancy
- Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis
- Interventions for tobacco use cessation in people living with HIV
- Interventions for smoking cessation in hospitalised patients
- Outpatient interventions for smoking cessation and reduction for adults with a mental disorder
- Interventions to reduce tobacco use in people experiencing homelessness
- By treatment provider (4)
- By treatment type (32)
- Medications (15)
- Cannabinoid type 1 receptor antagonists for smoking cessation
- Lobeline for smoking cessation
- Nicotine receptor partial agonists for smoking cessation
- Nicotine replacement therapy versus control for smoking cessation
- Nicotine vaccines for smoking cessation
- Interventions to increase adherence to medications for tobacco dependence
- Antidepressants for smoking cessation
- Opioid antagonists for smoking cessation
- Anxiolytics for smoking cessation
- Clonidine for smoking cessation
- Mecamylamine (a nicotine antagonist) for smoking cessation
- Nicobrevin for smoking cessation
- Silver acetate for smoking cessation
- Pharmacological interventions for smoking cessation: an overview and network meta-analysis
- Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
- Behavioural therapy (13)
- Stage-based interventions for smoking cessation
- Internet-based interventions for smoking cessation
- Mindfulness for smoking cessation
- Smoking reduction interventions for smoking cessation
- Mobile phone text messaging and app-based interventions for smoking cessation
- Group behaviour therapy programmes for smoking cessation
- Print-based self-help interventions for smoking cessation
- Physician advice for smoking cessation
- Behavioural interventions for smoking cessation: an overview and network meta-analysis
- Individual behavioural counselling for smoking cessation
- Motivational interviewing for smoking cessation
- Telephone counselling for smoking cessation
- Real-time video counselling for smoking cessation
- Combinations of medications and behavioural therapy (2)
- Complementary therapies (2)
- Medications (15)
- By tobacco delivery mechanism (3)
- Other interventions to help tobacco users quit (8)
- Exercise interventions for smoking cessation
- Incentives for smoking cessation
- Relapse prevention interventions for smoking cessation
- Competitions for smoking cessation
- Enhancing partner support to improve smoking cessation
- Biomedical risk assessment as an aid for smoking cessation
- Aversive smoking for smoking cessation
- Interventions for preventing weight gain after smoking cessation
- Organisation of care, and recruitment (6)
- Strategies to improve smoking cessation rates in primary care
- Interventions for recruiting smokers into cessation programmes
- Training health professionals in smoking cessation
- Healthcare financing systems for increasing the use of tobacco dependence treatment
- System change interventions for smoking cessation
- Use of electronic health records to support smoking cessation
- For specific groups of smokers (13)
- Interventions to prevent tobacco use (9)
- Preventing tobacco use in young people (7)
- Community interventions for preventing smoking in young people
- Interventions for preventing tobacco sales to minors
- Mass media interventions for preventing smoking in young people
- School-based programmes for preventing smoking
- Incentives for preventing smoking in children and adolescents
- Family-based programmes for preventing smoking by children and adolescents
- School policies for preventing smoking among young people
- Preventing smokers in certain areas (2)
- Preventing tobacco use in young people (7)
- Interventions to reduce harm in people who use tobacco (5)
- Other reviews managed by the Tobacco Addiction Group (8)
- Allergies (5)
- Diagnostic Test Accuracy (1)
- Haemoptysis (1)
- Transgender health (1)
- eLearning (0)
- The effects of quitting smoking (3)